Dr. Golding is one of the 3,097 rheumatology professionals who have received Foundation funding since the Foundation’s inception in 1985. In 2014, he received the Foundation’s Career Development Bridge Funding Award: K Supplement, which allowed him to study aberrant regulatory T cell (Treg) suppression of B cells in systemic lupus erythematosus. The primary focus of his research is to understand the number of different pathways in lupus and rheumatoid arthritis, in hopes that the knowledge could one day lead to new treatments for patients like Yolanda.
Explore this issueNovember 2016
Also by this Author
“There are a lot of things we know and a lot of things we don’t know. By asking these fundamental questions, hopefully we can ultimately come up with a new treatment for these diseases. Every research project that’s done, there is a seed for a future treatment.”